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Introduction
The development of family medicine (FM, synony-
mous with general practice) as a clinical speciality and
an academic discipline is informed and enhanced by
the collection of empirical longitudinal data from
routine clinical practice. The study of the epidemi-
ology of FM using electronic medical record (EMR)
databases is a classic example, empirically measuring
the content of actual practice and informing the
domains of research, education, policy planning and
clinical practice.1,2
The International Classiﬁcation of Primary Care
(ICPC) acts as an ordering principle for FM data,
allowing for direct comparisons, and also has the
appropriate granularity for primary care studies.3,4
The use of the episode of care (EoC) data model3,4
allows for increased precision in calculating incidence
and prevalence rates.2,5 In the Transition Project, such
data have been collected with ICPC in the Netherlands,
Japan, Poland, Malta, Serbia and other countries6–10
from the daily practice of a cohort of family doctors
(FDs) using similar methodology over a period of 1 to
11 years. These data allow the calculation of incidence
and prevalence rates per 1000 patient years of obser-
vation in a population, this being a controlled de-
nominator independent of consultation rates. The
datasets from the Netherlands, Malta and Serbia have
been used for this study because they are available and
validated, recent and overlap in time.5
At a recent European General Practice Research
Network (EGPRN; www.egprn.org) conference on
chronic disease in FM, at Nice in France, it was clear
that there is no international consensus deﬁnition as
to what is, and what is not, a chronic disease. As a lay
example of this issue, the Concise Oxford English
Dictionary deﬁnition is also rather vague, deﬁning
chronic (illness) as: ‘persisting for a long time or
constantly recurring’ (p. 255).11
The deﬁnition in the International Epidemiological
Association’sADictionary of Epidemiology is also non-
speciﬁc, referring to a ‘health-related state’ or an
‘exposure’ which is described as: ‘... lasting a long
time’ or ‘... prolonged or long term’, respectively
(p. 39)12 but then also referring to the United States
Centre forHealth Statistics as deﬁning such a period as
of ‘three months’ duration or longer’.12
TheWorldOrganisation of FamilyDoctors’ (Wonca)
International Dictionary for General/Family Practice is
more speciﬁc, and deﬁnes the term ‘chronic’ with a
deﬁned time: ‘relating to an illness or disability lasting
6 months or longer’.13
Such a time-framed deﬁnition would, however,
exclude conditions or health problems which do last
six months or more (or three months or more), but
which might not be considered an illness, or to cause
disability, such as mild spina biﬁda occulta, asym-
metry of the pupils, repeated consultations for smok-
ing prevention, monitoring of borderline lipid levels
or contraception.
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Background This is a study of the epidemiology of
acute and chronic episodes of care (EoCs) in the
Transition Project in three countries. We studied
the duration of EoCs for acute and chronic health
problems and the relationship of incidence to pre-
valence rates for these EoCs.
Method The Transition Project databases collect
data on all elements of the doctor–patient encoun-
ter in family medicine. Family doctors code these
elements using the International Classiﬁcation of
Primary Care.We used the data from three practice
populations to study the duration of EoCs and the
ratio of incidence to prevalence for common health
problems.
Results We found that chronic health problems
tended to have proportionately longer duration
EoCs, as expected, but also a lower incidence to
prevalence rate ratio than acute health problems.
Thus, the incidence to prevalence index could be
used to deﬁne a chronic condition as one with a low
ratio, below a deﬁned threshold.
Conclusions Chronic health problems tend to
have longer duration EoCs, proportionately, across
populations. This result is expected, but we found
important similarities and diﬀerences which make
deﬁning a problem as chronic on the basis of time
rather diﬃcult. The ratio of incidence to prevalence
rates has potential to categorise health problems
into acute or chronic categories, at diﬀerent ratio
thresholds (such as 20, 30 or 50%). It seems to
perform well in this study of three family practice
populations, and is proposed to the scientiﬁc com-
munity for further evaluation.
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We used data available from the Transition Project
databases to investigate the duration of health prob-
lems (EoC) in international primary care, and to look
for an empirical quantitative index of chronicity
appropriate for the domain of FM. We consider that
the increased precision of incidence and prevalence
rates aﬀorded by the use of ICPC in an EoCdatamodel
would provide new perspectives on chronic disease
and health problems.5
The research question of this study is: ‘What are the
similarities and diﬀerences in the duration of episodes
of care in diﬀerent countries?’
During the course of the study, we observed and
hereby describe an interesting phenomenon related to
the ratio of incidence to prevalence rates for acute and
chronic illnesses.
Method
The public-domain EMR TransHis (short for Tran-
sition Project Health Information System),14 designed
for use with ICPC, was used to collect data from
participating FDs who recorded details [reason(s)
for encounter, diagnosis(es) and intervention(s)] of
all their patient contacts in an EoC structure using
ICPC. Reasons for encounter presented by the patient,
all FD interventions and the diagnostic labels recorded
for each encounter were classiﬁed using ICPC (ICPC-
2-E in Malta and Serbia, ICPC-1 in the Netherlands).
Data for all encounters (face-to-face encounters in the
oﬃce and at home, telephone consultations, repeat
prescriptions, etc.) were analysed to obtain complete
data on incidence and prevalence, including for patients
presenting only for a repeat prescription.
An EoC is deﬁned as a health problem from its ﬁrst
presentation by the patient to the FD, until the com-
pletion of the last encounter for it. It encompasses all
contact elements related to that health problem. Its
name (i.e. the diagnostic label of the EoC) may be
modiﬁed over time, and in this article we refer to it as
the episode title. The last diagnosis made during an
EoC is the current episode title.4
The databases encompass a deﬁned period: an
average of 9896 patients and 43 577 patient years of
observation over ﬁve years in Malta (2001–2005),
15 318 patients and 158 370 patient years over 11 years
in the Netherlands (1995–2005), 72 673 patient years
over 1 year in Serbia (2003). The practice populations
in the Netherlands and Serbia represent registered
patient populations (for Serbs only those over 15 years
of age), whilst the population in Malta represents
patients consulting over a ﬁve-year period. The
databases were analysed using a one-year data-frame
over the whole available observation period to calcu-
late incidence and prevalence (according to the stan-
dard approach), but longer time frames were used to
study the duration of EoCs (four years for the Dutch
database and ﬁve years for the Maltese). An EoC open
over a number of years of observation would be recoded
as rest-prevalent (to distinguish it from new) in sub-
sequent data frames (one, four or ﬁve years, as appro-
priate), but only for those years when a consultation
for that same EoC occurred.
The databases were used to calculate incidence and
prevalence rates for EoCs. Rates are presented as
number of observations per 1000 person (patient)
years of observation. A patient-year starts at the
beginning of an observation frame or when a patient
registers in the practice, and is closed when the patient
leaves the practice for any reason, including death. In
the case of Malta, where patients are not registered
with the FD, but tend to see the same FD for most, but
possibly not all, healthcare problems, a patient-year
was opened when a patient presented to the FD for an
encounter. Any patients in the Maltese database who
did not consult in the observation period of ﬁve years
did not contribute to the denominator.
Incidence rates in this study give the rate of an
observation in new EoCs, i.e. at the ﬁrst encounter
at the start of a new EoC, per 1000 patient years of
observation. Prevalence rates give the rate of an
observation in all EoCs, both incident and rest-preva-
lent considered together, in that period of observation.
Rest-prevalent EoCs represent a health problem that is
not new, but has presented during that period of
observation for follow-up.
A patient can have more than one new EoC for the
same diagnosis during an observation period (say two
separate EoCs for bronchitis in one year). However,
software error trapping prevents the coding of a new
EoC for the same chronic health problem in one
patient, to prevent erroneous double coding of deﬁned
chronic problems. Rates of EoCs were standardised to
the European Union standard 25 country population
(EU25 population, 2005)15 to adjust for age and sex
diﬀerences in the practice populations under study.
The practice populations were treated as deﬁned
populations, and not as samples of a larger population
because they are not random samples of a deﬁned
geographical population. As such, conﬁdence inter-
vals for a population ‘estimate’ were inappropriate.
The EoCs studiedwere thosewhich described the 20
most prevalent EoCs in each of the three populations
under study, as published previously.5 The duration of
selected EoCs was calculated using the standard ap-
proach in the Episodes of Care in Family Practice (EFP)
program,9 but using amore recent database. The EoCs
analysed in Table 1 were selected as examples of acute
and chronic conditions, and the trends observed are
typical of other acute and chronic conditions in the
database (data available in EFP). The duration of an EoC
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is the period (in days) from the ﬁrst to the last encounter
for that same problem in that patient. The incidence to
prevalence ratio was a simple mathematical ratio
(equivalent to the incidence rate divided by the preva-
lence rate) expressed as a percentage and the mean ratio
was the simple unweightedmeanof the three population
rate ratios.
Ethical considerations
The study did not involve the collection of new data.
Ethical approval was applied for locally, when appro-
priate, for individual studies based on these data in the
Netherlands, Serbia and Malta.
Results
Table 1 gives the proportion (percentage) of EoCs
which last only one day, compared with those which
last six months or less, for selected acute and chronic
EoCs. For the two exemplar acute health problems,
namely upper respiratory tract infection (R74) and
acute tonsillitis (R76), the majority of EoCs had a
duration of only one day (percentage ranges from
57.1% for R74 in Serbia to 93.4% for R74 in Malta),
and more than 85% had a duration of up to six
months, in all three populations. By contrast, for the
four exemplar chronic health problems, namely asthma
(R96), hypertension (uncomplicated, K86), heart fail-
ure (K77) and depressive disorder (P76), the percent-
age of EoCs which lasted only one day was much
smaller in all three populations, ranging from7.9% for
K86 in theNetherlands to 63.9% for R96 inMalta. The
proportions of EoCs lasting sixmonths or less was also
much lower than that for acute health problems in all
three populations, ranging from 17.5% for K86 in the
Netherlands to 80.0% for K77 in Malta. The pro-
portion of EoCs lasting six months or less was 80.0%
or less for all the chronic problems, whilst for both
acute disorders this proportion was 85.1% or more.
EoCs for these chronic health problems in Malta ap-
peared to last less than in the Netherlands and Serbia,
with higher proportions of such EoCs lasting only one
day in the Maltese population.
Table 2 gives the incidence to prevalence rate ratio
for the 20 most common distributions of EoCs in the
three populations.5 Mean incidence to prevalence rate
ratios ranged from 9.0% (for complicated hyperten-
sion, K87) to 85.7% (for excessive ear wax, H81, and
gastroenteritis, D87), but some ratios lay outside even
this wide range, in one or more populations. Health
problems classically described as chronic had lower
incidence to prevalence rate ratios, both in individual
populations and on average: 11.8% for uncomplicated
hypertension (K86, unweighted mean of three popu-
lations), 15.0% for type II diabetes mellitus (T90,
Table 1 The percentage of new episodes of care lasting one day and lasting six months or
less, for a selection of health problems exemplifying acute or chronic disorders. Columns list
ICPC rubric and label, and percentage of episodes of care lasting one day or six months in
the Dutch population (four year data frame, Nl 4 yr), Maltese population (5 year data
frame, Mt 5 yr) and Serb population (1 year data frame, Sb)
NI 4 yr Mt 5 yr Sb
% of new episodes lasting one day
R74 – upper respiratory tract infection 85.7 93.4 57.1
R76 – acute tonsillitis 76.8 90.2 60.7
R96 – asthma 26.2 63.9 18.2
K86 – uncomplicated hypertension 7.9 41.8 18.5
K77 – heart failure 11.7 63.4 19.7
P76 – depressive disorder 21.8 53.1 22.6
% of new episodes lasting six months or less
R74 – upper respiratory tract infection 97.5 98.6 85.1
R76 – acute tonsillitis 98.2 98.3 89.0
R96 – asthma 44.1 75.2 42.5
K86 – uncomplicated hypertension 17.5 57.2 44.0
K77 – heart failure 36.2 80.0 48.7
P76 – depressive disorder 50.5 70.8 60.0
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Table 2 The ratio of incidence to prevalence rate for the twenty commonest ICPC episode titles5 in three populations. Columns list ICPC code,
ICPC label, prevalence and incidence rates in the Dutch, Maltese and Serb practices respectively (standardised for the EU 2005 population),15
the ratio of incident to prevalent episodes of care for that ICPC code in each population, and the mean incidence to prevalence ratio in the
three populations (un-weighted mean of previous three columns). Those ICPC rubrics which are below an incidence to prevalence threshold
ratio cut-oﬀ of 20%, 30% and 50%, respectively, are divided into boxes
The Netherlands Malta Serbia Incidence/Prevalence rate ratio
(Standardised EU 2005)
Code Label Prevalence Incidence Prevalence Incidence Prevalence Incidence The Netherlands Malta Serbia Mean
K87 Hypertension
complicated
10.9 0.5 6.2 0.3 15.3 2.7 4.6% 4.8% 17.6% 9.0%
K86 Uncomplicated
hypertension
79.2 5.5 59.9 6.2 79.8 14.4 6.9% 10.4% 18.0% 11.8%
W11 Family plan/oral
contraceptive
93.7 13.1 – – – – 14.0% – – 14.0%
T90 Diabetes non-
insulin dependent
33.3 4.3 28.8 4.5 19.9 3.3 12.9% 15.6% 16.6% 15.0%
K74 Ischaemic heart
dis with angina
16.0 2.8 7.9 1.9 14.0 2.6 17.5% 24.1% 18.6% 20.0% Threshold
20%
R96 Asthma 40.4 6.5 35.7 10.7 3.5 0.7 16.1% 30.0% 20.0% 22.0%
D85 Duodenal ulcer 3.5 0.6 0.3 – 26.2 8.6 17.1% – 32.8% 25.0%
P74 Anxiety disorder/
anxiety state
8.9 2.0 18.3 4.2 44.3 14.7 22.5% 23.0% 33.2% 26.2%
R79 Chronic
bronchitis
2.5 0.5 2.0 0.7 14.5 3.5 20.0% 35.0% 24.1% 26.4%
K77 Heart failure 14.9 3.6 10.4 3.9 10.2 2.0 24.2% 37.5% 19.6% 27.1%
P76 Depressive
disorder
36.9 10.2 25.8 7.5 7.1 1.8 27.6% 29.1% 25.4% 27.4% Threshold
30%
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Table 2 Continued
The Netherlands Malta Serbia Incidence/Prevalence rate ratio
(Standardised)
Code Label Prevalence Incidence Prevalence Incidence Prevalence Incidence The Netherlands Malta Serbia Mean Standardised
EU 2005
K80 Cardiac
arrhythmia NOS
2.7 1.0 0.2 - 14.6 3.7 37.0% - 25.3% 31.2%
P06 Disturbances of
sleep/insomnia
59.8 17.5 5.9 1.5 3.5 1.5 29.3% 25.4% 42.9% 32.5%
L84 Back syndrome
without radiat
pain
5.4 1.3 2.8 1.3 39.7 11.8 24.1% 46.4% 29.7% 33.4%
T93 Lipid
metabolism
disorder
41.4 7.9 28.8 11.4 14.9 8.6 19.1% 39.6% 57.7% 38.8%
R97 Hayfever/allergic
rhinitis
39.0 8.8 23.2 9.0 0.7 0.4 22.6% 38.8% 57.1% 39.5%
P01 Feeling anxious/
nervous/tense
30.9 13.1 14.2 8.2 10.7 3.7 42.4% 57.7% 34.6% 44.9%
L86 Back syndrome
with radiating
pain
24.9 13.1 14.7 8.5 32.0 9.6 52.6% 57.8% 30.0% 46.8%
L83 Neck syndrome 7.1 2.5 4.4 3.4 30.8 9.1 35.2% 77.3% 29.5% 47.3%
K85 Elevated blood
pressure
17.0 8.2 9.9 7.2 30.1 6.8 48.2% 72.7% 22.6% 47.9% Threshold
50%
P17 Tobacco abuse 7.7 4.5 21.3 1.5 7.3 6.5 58.4% 7.0% 89.0% 51.5%
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Table 2 Continued
D87 Stomach function
disorder
19.4 7.8 11.3 7.6 16.9 8.4 40.2% 67.3% 49.7% 52.4%
L03 Low back complt
excl radiation
56.9 41.7 3.7 2.8 4.7 2.0 73.3% 75.7% 42.6% 63.8%
A85 Adv eﬀect med
agent proper dose
36.9 31.6 24.0 17.5 0.2 0.1 85.6% 72.9% 50.0% 69.5%
S88 Contact
dermatitis/other
eczema
60.3 32.2 7.0 6.2 5.1 3.8 53.4% 88.6% 74.5% 72.2%
R75 Sinusitis acute/
chron
35.9 30.8 18.8 16.3 9.9 4.5 85.8% 86.7% 45.5% 72.7%
L18 Muscle pain 11.4 7.4 48.1 43.2 0.3 0.2 64.9% 89.8% 66.7% 73.8%
S74 Dermatophytosis 47.9 33.2 10.0 8.0 2.9 2.1 69.3% 80.0% 72.4% 73.9%
A98 Prevention 175.6 99.0 131.8 107.7 4.6 3.9 56.4% 81.7% 84.8% 74.3%
U71 Cystitis/other
urin infect NOS
59.0 50.2 17.6 15.5 36.5 19.6 85.1% 88.1% 53.7% 75.6%
A04 General weakness/
tiredness
38.0 30.9 5.4 4.5 1.2 0.8 81.3% 83.3% 66.7% 77.1%
R78 Acute bronchitis/
bronchiolitis
48.2 41.3 41.7 40.0 44.9 23.0 85.7% 95.9% 51.2% 77.6%
R05 Cough 50.1 41.8 24.3 20.3 2.4 1.6 83.4% 83.5% 66.7% 77.9%
R74 URI (head cold) 52.4 49.2 177.3 174.1 92.5 44.6 93.9% 98.2% 48.2% 80.1%
R29 Respiratory
symptom/
complaint other
0.7 0.6 22.2 21.3 0.5 0.3 85.7% 95.9% 60.0% 80.6%
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Table 2 Continued
The Netherlands Malta Serbia Incidence/Prevalence rate ratio
(Standardised)
Code Label Prevalence Incidence Prevalence Incidence Prevalence Incidence The Netherlands Malta Serbia Mean Standardised
EU 2005
R76 Tonsillitis acute 15.3 14.5 26.9 25.4 29.0 15.5 94.8% 94.4% 53.4% 80.9%
R77 Laryngitis/
tracheitis acute
15.1 14.0 15.6 14.8 6.2 3.6 92.7% 94.9% 58.1% 81.9%
A97 No disease 48.6 43.4 47.3 44.9 1.0 0.7 89.3% 94.9% 70.0% 84.7%
R80 Inﬂuenza 9.6 9.4 22.8 22.3 2.0 1.2 97.9% 97.8% 60.0% 85.2%
H81 Excessive ear wax 44.7 40.2 12.3 10.3 1.8 1.5 89.9% 83.7% 83.3% 85.7%
D73 Gastroenteritis
presumed
infection
15.5 14.9 70.7 69.9 8.7 5.4 96.1% 98.9% 62.1% 85.7%
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including both type I and type II in ICPC-1, used in the
Netherlands), 20.0% for ischaemic heart disease with
angina (K74) and 9.0% for complicated hypertension
(K87). Other health problems which might not be
immediately considered as chronic also had low ratios,
such as 14.0% for family planning (W11). One could
arbitrarily deﬁne a threshold for the rate ratio. Were a
line to be drawn at the 20, 30 or 50% level, diﬀerent
categories of health problems would be created, some
of which would include chronic health problems such
as asthma (R96, 22.0%), duodenal ulcer (D85, 25.0%),
chronic bronchitis (R79, 26.4%), heart failure (K77,
27.1%), depressive disorder (P76, 27.4%), cardiac ar-
rhythmia (K80, 31.2%), insomnia (P06, 32.5%), back
syndromewithout radiation (L84, 33.4%), lipid disorder
(T93, 38.8%), allergic rhinitis (R97, 39.5%), feeling
anxious (P01, 44.9%), back syndrome with radiation
(L86, 46.8%), neck syndrome (L83, 47.3%) and elev-
ated blood pressure (excluding hypertension, K85,
47.9%). Health problems with classically more acute
presentations had higher incidence to prevalence rate
ratios, such as cystitis (U71, 75.6%), upper respiratory
tract infection (R74, 80.1%), acute tonsillitis (R76,
80.9%) and inﬂuenza (R80, 85.2%). Some health
problems which might be considered chronic, or
which included both acute and chronic cases, also
had high incidence to prevalence rate ratios, such as
tobacco abuse (P17, 51.5%), stomach function dis-
order (D87, 52.4%), contact dermatitis (S88, 72.2%),
and sinusitis acute/chronic (R75, 72.7%). However,
such ratios did appear lower in individual populations
for some of these health problems.
Discussion
Principal ﬁndings
We analysed the percentage of EoCs for selected
common problems which last for one day or for up
to six months, and the ratio of incidence to prevalence
rates for a distribution of the 20 most common prob-
lems seen by the FD in three FM populations.
We found that the selected chronic problems had
proportionately more EoCs which lasted longer than
six months, when compared to the selected acute
problems. Such ﬁndings are typical for the data we
have collected, and we have presented only some
examples. The proportion of acute and chronic prob-
lemswhich lasted one day, or sixmonths or less, varied
between populations. However, 80% or fewer EoCs
for chronic problems lasted for at least six months,
whereas 85% or more of acute problems lasted for
up to six months, across all three populations. The
variability in the duration of EoCs for these health
problems between countries represents a challenge for
deﬁning a cut-oﬀ period for classifying a problem as
chronic in international FM.
The ratio of incidence to prevalence rates was found
to be a useful indicator of acute as against chronic
categorisation of a health problem. Health problems
with a low rate ratio tended to be chronic, and this was
consistent with the percentage of such EoCs which
lasted for one day or up to six months, described
above. By contrast, acute problems tended to have a
higher incidence to prevalence rate ratio, and a higher
proportion of such EoCs lasted for only one day.
Chronic health problems thus tended to have a lower
incidence to prevalence rate ratio than acute health
problems.
This study describes a new empirical index of
chronicity, namely the ratio of incidence to prevalence
rates.
Implications of the ﬁndings
The incidence to prevalence rate ratio could be used as
an index to deﬁne a chronic condition as one with a
low ratio, below a deﬁned ‘cut-oﬀ ’ threshold level and
independent of a speciﬁc duration period. Thresholds
of 20, 30 or 50% would identify diﬀerent sets of
conditions as chronic, and others as not.
Comparisons with the literature
As discussed above, current deﬁnitions of the chron-
icity of a health problem or a disability11–13 tend to be
either too vague or too speciﬁc. Deﬁning a chronic
problem on the basis of a deﬁned periodmay be useful
for epidemiological purposes and for deﬁning cases
in clinical practice, but it has its limitations due to
variability in the mean duration of EoCs in diﬀerent
healthcare systems. EoCs of chronic disease or health
problems may last for less than six months, for
example, due to poor follow-up or patient default.
Using a shorter or longer cut-oﬀ period may partly
address this issue, but does not fully address the issue
of the individual patient with a disease at its ﬁrst
presentation. Newly incident diabetes in a patientmay
be described as a chronic disease because the condition
is likely to be life-long. In this case, it is the mean
duration of the illness or disability which is useful in
deﬁning it as chronic or acute. However, the mean
duration of EoCs varies in diﬀerent settings.
The use of an index such as the ratio of incidence to
prevalence rates, rather than a deﬁned period, has the
advantage of allowing one to deﬁne a threshold on the
basis of the presentation of the problem. If a health
problem is more often manifest as a follow-up for a
pre-existing healthcare issue, rather than as an inci-
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dent problem, this will aﬀect the ratio. This has the
attraction of avoiding an arbitrarily deﬁned period.
Additionally, it allows use of the incidence to preva-
lence rate ratio as ameasure of the ‘degree of chronicity’,
allowing comparisons between healthcare problems in
clinical practice. In this sense, it also is useful in
examining the pattern of presentation of the problem
to healthcare services, and the type of burden of disease
that the problem presents to the patient and the health
care system.
For example, one may comment on the fact that
back problems with a deﬁned disease label diagnosis,
such as ‘back syndrome’ with or without radiation
(L86 and L87 respectively in ICPC), had a lower mean
rate ratio (46.8 and 33.4%, respectively), than EoCs
for the symptom diagnosis ‘low back pain’ not classi-
ﬁed with a disease label diagnosis (63.8%). The rate
ratio for heart failure (K77) was 27.1% (ranging from
19.6% in Serbia to 37.5% in Malta), which is a better
indicator than the data on the proportion of EoCs for
K77 lasting up to sixmonths inTable 1. The number of
cases of heart failure lost to follow-up inMalta, due to
healthcare system eﬀects, may have an impact on EoC
duration data, but the incidence to prevalence rate
ratio may be a better indicator of the nature of the
health problem over time.
Limitations
This was a study of data structured using EoCs, and
not episodes of illness, in the community. The data on
the actual prevalence and incidence of illness in the
community were not available, due to the study being
based at a practice population level, on actual consul-
tations with the FD.
The use of the EoC data model allows more precise
estimates of incidence and prevalence, which is a
strength.3,5 However, many information systems
may not allow EoC coding, or may not allow easy
analysis of diagnostic data structured in EoCs even
though the datum may be coded. Thus, replicating
this study may be challenging in other settings and
with other datasets.
This is a preliminary study of the incidence to
prevalence index, and the indicator must be further
tested in other datasets and other populations, before
it is widely used. The implications of a high or a low
index ratio must also be further understood, and their
application to patient care further studied.
Strengths
The fact that the EMR TransHis guides and supports
the doctor during coding, providing ICPC coding
criteria and software error trapping, improves the
quality of the data collected, which in turn improves
its reliability. The software and classiﬁcation system
provide data which allow the calculation of precise
incidence and prevalence rates of EoCs in these pri-
mary care populations from these three countries. The
use of an EoC model corrects for diverse artefacts of
observation, including the eﬀect of multiple consul-
tations for the same problem, and this allows the
correct interpretation of multiple incident episodes
in one individual in a deﬁned period of observation.
Other artefacts, such as the paradoxical increase in
incidence in the very old (over 85 years of age) due to
high mortality rates, are adjusted for by the accurate
patient year denominator in this project. These qual-
ities of these databases are a substantial strength, which
supports the conclusions of this study.
Call for further research
More research in this area, ondiﬀerent datasets, would
allow an optimum threshold to be deﬁned to categor-
ise disorders into those with a more chronic, more
acute, and intermediate pattern of presentation on the
basis of ratios of incident to prevalent EoCs.
Conclusions
The duration of EoCs for acute and chronic health
problems varies between the populations studied.Never-
theless, chronic health problems tended to have longer
duration EoCs, proportionately, across populations.
This is to be expected, but we found important
similarities and diﬀerences. This observation makes the
deﬁnition of a temporal cut-oﬀ for deﬁning a health
problem as chronic rather problematic at an inter-
national level.
We found that the ratio of incidence to prevalence
rates has potential to categorise health problems into
acute or chronic categories, at diﬀerent ratio thresholds
(such as 20, 30 or 50%). It seems to performwell in this
study of three FM practice populations, and is pro-
posed to the scientiﬁc community for further evalu-
ation.
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